Positive Perspectives 3 study finds widespread communication barriers: Half of people living with HIV feel unheard by healthcare providers despite high trust.
London, 27 May 2025 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced interim data from the third wave of the global Positive Perspectives (PP3) study of people living with HIV. Initial results show that while a high proportion of individuals trust their healthcare provider (HCP), a communications gap exists. Many indicated that they sometimes feel unheard by their HCP, and did not make decisions together about their current antiretroviral (ART) regimen. Those who were satisfied with their ART regimen were less likely to intentionally skip doses and more likely to report good overall health outcomes.
Read the full company press release here.
Source : ViiV Healthcare
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.